Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson monthly Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E20.19 EPS (ttm)6.40 Insider Own0.07% Shs Outstand2.81B Perf Week-2.74%
Market Cap363.60B Forward P/E14.16 EPS next Y9.13 Insider Trans0.16% Shs Float2.64B Perf Month-1.93%
Income17.23B PEG3.39 EPS next Q1.88 Inst Own70.00% Short Float0.63% Perf Quarter-0.45%
Sales81.71B P/S4.45 EPS this Y7.60% Inst Trans0.12% Short Ratio2.16 Perf Half Y-7.18%
Book/sh22.92 P/B5.64 EPS next Y5.27% ROA9.60% Target Price150.19 Perf Year-7.08%
Cash/sh5.43 P/C23.80 EPS next 5Y5.95% ROE24.10% 52W Range121.00 - 148.99 Perf YTD0.12%
Dividend3.80 P/FCF41.16 EPS past 5Y3.10% ROI17.00% 52W High-12.78% Beta0.70
Dividend %2.94% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.60% 52W Low7.39% ATR2.72
Employees135100 Current Ratio1.30 Sales Q/Q-1.30% Oper. Margin20.70% RSI (14)48.61 Volatility2.53% 1.77%
OptionableYes Debt/Eq0.48 EPS Q/Q43.40% Profit Margin18.00% Rel Volume0.61 Prev Close129.20
ShortableYes LT Debt/Eq0.46 EarningsOct 15 BMO Payout65.60% Avg Volume7.72M Price129.95
Recom2.10 SMA20-0.77% SMA50-0.33% SMA200-3.44% Volume2,918,234 Change0.58%
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Oct-23-19 09:22AM  Does Johnson & Johnson (NYSE:JNJ) Have A Healthy Balance Sheet? Simply Wall St.
08:00AM  J&J Recalls Baby Powder After Asbestos Find Is JNJ Stock A Safe Buy? Investor's Business Daily
06:00AM  Health-Care Stocks Gain as Elizabeth Warrens Victory Looks Less Assured
Oct-22-19 04:01PM  Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell Reuters
11:32AM  Drug/Biotech Stock Q3 Earnings on Oct 23: LLY, ALXN & More Zacks
11:25AM  Medical Products' Earnings Roster for Oct 23: TMO, BSX & More Zacks
10:11AM  Biogen (BIIB) Beats on Q3 Earnings, Eyes FDA Nod for Aducanumab Zacks
Oct-21-19 10:23PM  The 3 Best Stocks to Buy and Hold (Forever) Investopedia
06:56PM  October brings losses for short sellers in U.S. opioid-related shares Reuters
06:12PM  Shapiro, state AGs announce tentative $48B national opioid settlement American City Business Journals
05:50PM  Drug Companies Strike $48 Billion Deal In Opioid Crisis With Four States Investor's Business Daily
01:19PM  How 16 Blue Chip Stocks Are Getting Squeezed by Strong Dollar Investopedia
01:03PM  Get Real. There Will Be a Global Opioid Settlement. Bloomberg
12:24PM  J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos Zacks
11:40AM  How Much Litigation Risk Is Priced Into Johnson & Johnson? Benzinga
09:35AM  Stock Market News for Oct 21, 2019 Zacks
09:12AM  McKesson Among Four to Pay Over $250 Million in Opioid Case Bloomberg
09:08AM  4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain Benzinga
08:40AM  Theres Still No Global Deal on Opioid Litigation, but Distributors Will Sit Out Monday Trial
08:08AM  REFILE-UPDATE 8-Drug companies avert landmark opioids trial as talks on $48 bln settlement set to resume Reuters
07:12AM  Johnson & Johnson stock pummeled after asbestos-related baby powder recall MarketWatch
06:30AM  Energy Stocks Are Getting Hammered
04:19AM  5 Stocks Set to Lead Longterm as Fed Rate Cuts Deepen Investopedia
Oct-20-19 06:56PM  Purdue Pharma creditors committee urges one mass settlement for all opioid lawsuits MarketWatch
07:00AM  Market Weekend: Brexit Purgatory, Syria Troops to Iraq, J&J Arsenic, JPMorgan Big Liquidity Thing Market Exclusive
Oct-19-19 12:40PM  Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More Benzinga
08:00AM  JNJ sheds light on why its settling some opioid cases instead of fighting in court Yahoo Finance
Oct-18-19 08:44PM  5 Dividend Stocks With Safe and Growing Payouts When Bonds Cant Do the Trick -6.22%
07:07PM  US Stocks Decline Friday
07:00PM  US Indexes Close Lower Friday After Weak China Data Report
05:50PM  J&J Recalls Lot of Baby Powder After Asbestos Trace Found Bloomberg
05:07PM  Stocks - S&P Knocked Down by Boeing, JNJ, China
05:05PM  Dow ends lower pressured by Boeing, Johnson & Johnson, despite good earnings MarketWatch
05:03PM  [video]Game Plan for Earnings: Cramer's 'Mad Money' Recap (Friday 10/18/19)
04:40PM  J&J Stock Plunges After FDA Test Finds Asbestos In Baby Powder Investor's Business Daily
04:23PM  US STOCKS-Boeing, J&J, dismal China data drag Wall Street lower Reuters
04:02PM  US STOCKS SNAPSHOT-Boeing, J&J pull down Wall Street along with weak China data Reuters
03:35PM  Johnson & Johnson recalls baby powder, the subject of a $4.7 billion St. Louis verdict American City Business Journals
03:28PM  Bad Day On Stock Market Continues; These Two Stocks Took Down The Dow Investor's Business Daily
02:45PM  Boeing, Johnson & Johnson share losses lead Dow's 200-point drop MarketWatch
02:27PM  US STOCKS-Wall Street weighed by Boeing, J&J, bleak China data Reuters
02:24PM  FDA alerts consumers of J&J baby powder recall, says it stands by tests Reuters
02:13PM  Boeing's stock selloff a triple-digit point drag on the Dow MarketWatch
01:47PM  US STOCKS-Wall St pressured by J&J, Boeing; growth worries linger Reuters
01:29PM  Tech Stocks Lead Selling As Boeing, J&J Hit The Dow Jones Industrial Average Investor's Business Daily
12:59PM  Johnson & Johnson Stock Falls on Baby Powder Recall
12:45PM  Jim Cramer: Johnson & Johnson's Baby Powder Recall Is 'Suboptimal'
12:30PM  UPDATE 2-Opioids settlement could be near, lawyer for local governments says Reuters
12:23PM  Dow industrials skid 200 points lower in midday action as J&J and Boeing's stock produce 100-point headwind MarketWatch
12:17PM  US STOCKS-Wall Street pressured by J&J, global growth concerns Reuters
12:15PM  Johnson & Johnson, Boeing share losses lead Dow's 139-point fall MarketWatch
12:14PM  Stock Market Extends Losses, But These 2 Dow Stocks Are Near Buy Points Investor's Business Daily
11:23AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Pfizer, Qualcomm and Mitsubishi UFJ Financial Zacks
11:13AM  3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
10:57AM  Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow Zacks
10:51AM  Options Bears Blast Johnson & Johnson After Baby Powder Recall Schaeffer's Investment Research
10:28AM  US STOCKS-Wall St treads water as earnings counter China data gloom; J&J falls Reuters
10:16AM  Dow Jones Falls In Weak Stock Market Action; Intuitive Surgical Is Breaking Out Today Investor's Business Daily
10:08AM  Its Crunch Time for an Opioid Settlement Before Key Trial Starts
10:05AM  Johnson & Johnson, American Express share losses lead Dow's 70-point fall MarketWatch
09:57AM  Settling Opioid Suits Probably Wont End the Crisis Bloomberg
09:39AM  Dow breaks slightly lower at Friday's open as J&J's stock weighs on blue chips MarketWatch
09:36AM  US STOCKS SNAPSHOT-Wall St opens lower as J&J slips Reuters
09:03AM  Johnson & Johnson's stock drops after baby powder recall MarketWatch
08:38AM  Johnson & Johnson Consumer Inc. To Voluntarily Recall A Single Lot Of Johnson's Baby Powder In The United States PR Newswire
08:07AM  UPDATE 2-WHO hails 'triumph' as Merck's Ebola vaccine gets EU green light Reuters
07:26AM  J&J's depression drug Spravato wins European panel vote Reuters
Oct-17-19 08:00PM  UPDATE 1-Judge summons drug company CEOs to discuss opioid settlement - source Reuters
05:14PM  Edited Transcript of JNJ earnings conference call or presentation 15-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
04:28PM  Drug Suppliers Reportedly Near $50 Billion Deal In Opioid Lawsuits Investor's Business Daily
04:00PM  Top Stock Reports for Johnson & Johnson, Boeing & Pfizer Zacks
03:38PM  Why Health Care Stocks Can Rebound Despite 2020 Election Turmoil Investopedia
01:20PM  UPDATE 1-J&J agrees to pay about $117 mln to settle U.S. states' mesh probe Reuters
12:32PM  Johnson & Johnson agrees to pay about $117 million to settle U.S. states' mesh probe Reuters
11:45AM  Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2019 PR Newswire
11:31AM  Judge summons drug company CEOs to court to discuss opioid settlement: source Reuters
11:18AM  Judge summons drug company CEOs to court to discuss opioid settlement - source Reuters
10:27AM  Teva Stock Is Jumping After Reports It May Trade Generic Drugs for an Opioid Settlement
09:45AM  Dow's 69-point jump led by gains for shares of Johnson & Johnson, JPMorgan Chase MarketWatch
09:35AM  Drug Distributor Stocks Rally Amid Opioid Talks Investopedia
07:00AM  Market Morning: Chinese Aircraft Carriers, DUP Sours on Brexit Deal, Big Opioid Settlement Market Exclusive
Oct-16-19 08:38PM  Broad opioid settlement talks heat up as federal trial looms MarketWatch
06:33PM  Johnson & Johnson Stock Rebounds After Earnings Investopedia
05:39PM  Johnson & Johnson's 3 Most Profitable Lines of Business (JNJ) Investopedia
05:24PM  PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks Benzinga
04:31PM  Stock market news: October 16, 2019 Yahoo Finance
03:19PM  Large Option Traders Aren't Buying The Johnson & Johnson Rally Benzinga
02:26PM  Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom Benzinga
01:44PM  Dow Gets A Boost From These 3 Key Stocks, But Software Thumps Nasdaq Investor's Business Daily
12:28PM  St. Louis court tosses $110M talc verdict against Johnson & Johnson American City Business Journals
12:02PM  'High-level dope dealers': Democratic candidates sound off on big pharma Yahoo Finance
11:56AM  Opioid Drug Companies Rally On Hopes of Broader Settlement Benzinga
11:38AM  McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks MarketWatch
11:05AM  Dow flat in spite of gains in Johnson & Johnson, Dow Inc. shares MarketWatch
10:40AM  J&J Makes $4 Billion Opioid Offer as Distributors Seek Deal Bloomberg
10:05AM  JNJ Beats, Ups View: Healthcare ETFs to Buy Zacks
09:57AM  Stock Market News for Oct 16, 2019 Zacks
09:46AM  Cardinal Health Stock, Other Drug Distributors, Jump on Possible Opioid Settlement
09:37AM  The S&P 500 may be one decent day of gains away from a breakout MarketWatch
08:01AM  Dow Jones Futures: Chip Leader ASML Leads Key Movers As Stock Market Rally Steps Up Investor's Business Daily
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM